A new trading day began on Tuesday, with Merck & Co Inc (NYSE: MRK) stock price down -2.06% from the previous day of trading, before settling in for the closing price of $98.93. MRK’s price has ranged from $73.31 to $105.84 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 12.04% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 17.25%. With a float of $2.48 billion, this company’s outstanding shares have now reached $2.49 billion.
Merck & Co Inc (MRK) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Merck & Co Inc is 0.10%, while institutional ownership is 79.83%. The most recent insider transaction that took place on Nov 10 ’25, was worth 616,395. In this transaction Chief Comm. & Public Afrs Ofcr of this company sold 7,085 shares at a rate of $87.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 10 ’25, when Company’s Officer proposed sale 7,085 for $87.00, making the entire transaction worth $616,395.
Merck & Co Inc (MRK) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 1.72 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.13% during the next five years compared to 12.04% growth over the previous five years of trading.
Merck & Co Inc (NYSE: MRK) Trading Performance Indicators
Here are Merck & Co Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.76. Likewise, its price to free cash flow for the trailing twelve months is 18.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.56, a number that is poised to hit 2.05 in the next quarter and is forecasted to reach 8.82 in one year’s time.
Technical Analysis of Merck & Co Inc (MRK)
Let’s dig in a bit further. During the last 5-days, its volume was 14.19 million. That was inferior than the volume of 14.66 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 10.50%.
During the past 100 days, Merck & Co Inc’s (MRK) raw stochastic average was set at 69.33%, which indicates a significant increase from 25.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.78 in the past 14 days, which was higher than the 2.07 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $91.09, while its 200-day Moving Average is $84.90. However, in the short run, Merck & Co Inc’s stock first resistance to watch stands at $99.14. Second resistance stands at $101.39. The third major resistance level sits at $102.94. If the price goes on to break the first support level at $95.35, it is likely to go to the next support level at $93.80. The third support level lies at $91.55 if the price breaches the second support level.
Merck & Co Inc (NYSE: MRK) Key Stats
With a market capitalization of 240.48 billion, the company has a total of 2,482,023K Shares Outstanding. Currently, annual sales are 64,168 M while annual income is 17,117 M. The company’s previous quarter sales were 17,276 M while its latest quarter income was 5,785 M.
